Salivary mucins in host defense and disease prevention

Mucus forms a protective coating on wet epithelial surfaces throughout the body that houses the microbiota and plays a key role in host defense. Mucins, the primary structural components of mucus that creates its viscoelastic properties, are critical components of the gel layer that protect against invading pathogens. Altered mucin production has been implicated in diseases such as ulcerative colitis, asthma, and cystic fibrosis, which highlights the importance of mucins in maintaining homeostasis. Different types of mucins exist throughout the body in various locations such as the gastrointestinal tract, lungs, and female genital tract, but this review will focus on mucins in the oral cavity. Salivary mucin structure, localization within the oral cavity, and defense mechanisms will be discussed. These concepts will then be applied to present what is known about the protective function of mucins in oral diseases such as HIV/AIDS, oral candidiasis, and dental caries.

[1]  G. Carpenter,et al.  SIgA Binding to Mucosal Surfaces Is Mediated by Mucin-Mucin Interactions , 2015, PloS one.

[2]  Alexander D. Johnson,et al.  Mucins Suppress Virulence Traits of Candida albicans , 2014, mBio.

[3]  K. Ribbeck,et al.  Salivary Mucins Protect Surfaces from Colonization by Cariogenic Bacteria , 2014, Applied and Environmental Microbiology.

[4]  G. Carpenter,et al.  Concentration of salivary protective proteins within the bound oral mucosal pellicle. , 2014, Oral diseases.

[5]  T. Jowitt,et al.  Assembly of the Respiratory Mucin MUC5B , 2014, The Journal of Biological Chemistry.

[6]  Agnieszka Gornowicz,et al.  Mucin levels in saliva of adolescents with dental caries , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[7]  Ivana V. Yang,et al.  Muc5b is required for airway defence , 2013, Nature.

[8]  K. Adler,et al.  Regulated Mucin Secretion from Airway Epithelial Cells , 2013, Front. Endocrinol..

[9]  S. Feng,et al.  Quantitative analysis of differentially expressed saliva proteins in human immunodeficiency virus type 1 (HIV-1) infected individuals. , 2013, Analytica chimica acta.

[10]  F. Scannapieco,et al.  Host Defense Proteins Derived from Human Saliva Bind to Staphylococcus aureus , 2013, Infection and Immunity.

[11]  P. Roux,et al.  The role of crude saliva and purified salivary mucins in the inhibition of the Human Immunodeficiency Virus type 1 , 2012, Virology Journal.

[12]  P. Roux,et al.  Anti-HIV-1 activity of salivary MUC5B and MUC7 mucins from HIV patients with different CD4 counts , 2010, Virology Journal.

[13]  Y. Hathout,et al.  MUC5B Is the Predominant Mucin Glycoprotein in Chronic Otitis Media Fluid , 2010, Pediatric Research.

[14]  N. Bannert,et al.  Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes , 2010, Cellular microbiology.

[15]  J. Griffith,et al.  Unpacking a gel-forming mucin: a view of MUC5B organization after granular release. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[16]  D. Thornton,et al.  Identification of salivary mucin MUC7 binding proteins from Streptococcus gordonii , 2009, BMC Microbiology.

[17]  M. Lis,et al.  Proteomic and metabolic characterization of a Candida albicans mutant resistant to the antimicrobial peptide MUC7 12-mer. , 2008, FEMS immunology and medical microbiology.

[18]  D. Rogers,et al.  Proteomic analysis of polymeric salivary mucins: no evidence for MUC19 in human saliva. , 2008, The Biochemical journal.

[19]  V. Korolik,et al.  Mucins in the mucosal barrier to infection , 2008, Mucosal Immunology.

[20]  Silke Schelenz,et al.  Management of candidiasis in the intensive care unit. , 2008, The Journal of antimicrobial chemotherapy.

[21]  J. Ship,et al.  Dry mouth and its effects on the oral health of elderly people. , 2007, Journal of the American Dental Association.

[22]  J. Perez-Vilar,et al.  Gel-forming mucins. Notions from in vitro studies. , 2007, Histology and histopathology.

[23]  U. Elofsson,et al.  Salivary mucin MUC5B could be an important component of in vitro pellicles of human saliva: an in situ ellipsometry and atomic force microscopy study. , 2007, Biomacromolecules.

[24]  J. Perez-Vilar.  Mucin granule intraluminal organization. , 2007, American journal of respiratory cell and molecular biology.

[25]  T. Mikami,et al.  Hyphal formation of Candida albicans is inhibited by salivary mucin. , 2007, Biological & pharmaceutical bulletin.

[26]  C. Douglas,et al.  Relationship between the ability of oral streptococci to interact with platelet glycoprotein Ibalpha and with the salivary low-molecular-weight mucin, MG2. , 2006, FEMS immunology and medical microbiology.

[27]  C. de Beer,et al.  The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay , 2006, Virology Journal.

[28]  J. Meijerink,et al.  Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. , 2006, Gastroenterology.

[29]  Rama Bansil,et al.  Mucin structure, aggregation, physiological functions and biomedical applications , 2006 .

[30]  S. Batra,et al.  Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. , 2006, Biochimica et biophysica acta.

[31]  S. Fisher,et al.  Binding of the Streptococcal Surface Glycoproteins GspB and Hsa to Human Salivary Proteins , 2006, Infection and Immunity.

[32]  F. Oppenheim,et al.  Two-hybrid analysis of human salivary mucin MUC7 interactions. , 2005, Biochimica et biophysica acta.

[33]  R. Gregory,et al.  Streptococcus mutans Surface α-Enolase Binds Salivary Mucin MG2 and Human Plasminogen , 2004, Infection and Immunity.

[34]  Reen Wu,et al.  Genome-wide search and identification of a novel gel-forming mucin MUC19/Muc19 in glandular tissues. , 2004, American journal of respiratory cell and molecular biology.

[35]  M. Levine,et al.  Structural features of the human salivary mucin, MUC7 , 1998, Glycoconjugate Journal.

[36]  H. Koop,et al.  Involvement of human mucous saliva and salivary mucins in the aggregation of the oral bacteria Streptococcus sanguis, Streptococcus oralis, and Streptococcus rattus , 1990, Antonie van Leeuwenhoek.

[37]  R. Gregory,et al.  Streptococcus mutans surface alpha-enolase binds salivary mucin MG2 and human plasminogen. , 2004, Infection and immunity.

[38]  T. Hardingham,et al.  Calcium-dependent Protein Interactions in MUC5B Provide Reversible Cross-links in Salivary Mucus* , 2003, Journal of Biological Chemistry.

[39]  A. Hand,et al.  Electron Microscopic Immunogold Localization of Salivary Mucins MG1 and MG2 in Human Submandibular and Sublingual Glands , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[40]  P. Toselli,et al.  Expression of Membrane-associated Mucins MUC1 and MUC4 in Major Human Salivary Glands , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[41]  S. Fisher,et al.  The salivary mucin MG1 (MUC5B) carries a repertoire of unique oligosaccharides that is large and diverse. , 2002, Glycobiology.

[42]  S. Batra,et al.  Structural organization and classification of the human mucin genes. , 2001, Frontiers in bioscience : a journal and virtual library.

[43]  F. Oppenheim,et al.  Physical and chemical aspects of saliva as indicators of risk for dental caries in humans. , 2001, Journal of dental education.

[44]  S. Carrington,et al.  Distribution of MUC1 in the normal human oral cavity is localized to the ducts of minor salivary glands. , 2001, Archives of oral biology.

[45]  A. Choudhury,et al.  Alternate splicing at the 3'-end of the human pancreatic tumor-associated mucin MUC4 cDNA. , 2001, Teratogenesis, carcinogenesis, and mutagenesis.

[46]  G. Offner,et al.  Heterogeneity of High-molecular-weight Human Salivary Mucins , 2000, Advances in dental research.

[47]  M. Levine,et al.  Divergent solid-phase synthesis and candidacidal activity of MUC7 D1, a 51-residue histidine-rich N-terminal domain of human salivary mucin MUC7. , 2000, The journal of peptide research : official journal of the American Peptide Society.

[48]  N. Porchet,et al.  Evolution of the large secreted gel-forming mucins. , 2000, Molecular biology and evolution.

[49]  T. Osaki,et al.  Regulation of Candida albicans growth and adhesion by saliva. , 2000, The Journal of laboratory and clinical medicine.

[50]  L. Bromberg,et al.  Self-association of mucin. , 2000, Biomacromolecules.

[51]  L. Bobek,et al.  In Vitro Assessment of Antifungal Therapeutic Potential of Salivary Histatin-5, Two Variants of Histatin-5, and Salivary Mucin (MUC7) Domain 1 , 2000, Antimicrobial Agents and Chemotherapy.

[52]  S. Filler,et al.  Role of Hyphal Formation in Interactions ofCandida albicans with Endothelial Cells , 2000, Infection and Immunity.

[53]  P. Denny,et al.  Salivary mucin as related to oral Streptococcus mutans in elderly people. , 2000, Oral microbiology and immunology.

[54]  B. Liu,et al.  The recombinant N-terminal region of human salivary mucin MG2 (MUC7) contains a binding domain for oral Streptococci and exhibits candidacidal activity. , 2000, The Biochemical journal.

[55]  A. Zalewska,et al.  Structure and biosynthesis of human salivary mucins. , 2000, Acta biochimica Polonica.

[56]  M. Levine,et al.  Candidacidal activity prompted by N-terminus histatin-like domain of human salivary mucin (MUC7)1. , 1999, Biochimica et biophysica acta.

[57]  N. Packer,et al.  Salivary mucin MG1 is comprised almost entirely of different glycosylated forms of the MUC5B gene product. , 1999, Glycobiology.

[58]  N. Packer,et al.  Salivary mucin MG 1 is comprised almost entirely of different glycosylated forms of the MUC 5 B gene product , 1999 .

[59]  S. Gendler,et al.  Cystic fibrosis mice lacking Muc1 have reduced amounts of intestinal mucus. , 1998, The Journal of clinical investigation.

[60]  D. Thornton,et al.  Isolation and physical characterization of the MUC7 (MG2) mucin from saliva: evidence for self-association. , 1998, The Biochemical journal.

[61]  R. Hill,et al.  Porcine Submaxillary Mucin Forms Disulfide-linked Multimers through Its Amino-terminal D-domains* , 1998, The Journal of Biological Chemistry.

[62]  B. Appelmelk,et al.  Neutrophil-Activating Protein Mediates Adhesion ofHelicobacter pylori to Sulfated Carbohydrates on High-Molecular-Weight Salivary Mucin , 1998, Infection and Immunity.

[63]  I. van Seuningen,et al.  Genomic Organization of the 3′ Region of the Human Mucin GeneMUC5B * , 1997, The Journal of Biological Chemistry.

[64]  J. Orenstein,et al.  Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues. , 1997, The American journal of pathology.

[65]  H. Wandall,et al.  Identification of a major human high molecular weight salivary mucin (MG1) as tracheobronchial mucin MUC5B. , 1997, Glycobiology.

[66]  H. Friedman,et al.  Human submandibular saliva specifically inhibits HIV type 1. , 1997, AIDS research and human retroviruses.

[67]  F. Oppenheim,et al.  Human Salivary Mucin MG1 Selectively Forms Heterotypic Complexes with Amylase, Proline-rich Proteins, Statherin, and Histatins , 1997, Journal of dental research.

[68]  F. Scannapieco,et al.  Role of Type 1 Fimbriae in the Adhesion of Escherichia coli to Salivary Mucin and Secretory Immunoglobulin A , 1996, Current Microbiology.

[69]  R. Hill,et al.  Porcine Submaxillary Mucin Forms Disulfide-bonded Dimers between Its Carboxyl-terminal Domains (*) , 1996, The Journal of Biological Chemistry.

[70]  E. Veerman,et al.  Salivary mucins: protective functions in relation to their diversity. , 1995, Glycobiology.

[71]  P. Bork,et al.  The SEA module: A new extracellular domain associated with O‐glycosylation , 1995, Protein science : a publication of the Protein Society.

[72]  A. Jamieson,et al.  Viscoelastic properties of human tracheobronchial mucin in aqueous solution , 1995, Biopolymers.

[73]  E. Veerman,et al.  Binding of Human High-molecular-weight Salivary Mucins (MG1) to Hemophilus parainfluenzae , 1995, Journal of dental research.

[74]  L. Tabak.  In defense of the oral cavity: structure, biosynthesis, and function of salivary mucins. , 1995, Annual review of physiology.

[75]  L. Epstein,et al.  Interaction of HIV-1 and human salivary mucins. , 1994, Journal of acquired immune deficiency syndromes.

[76]  D. Henrard,et al.  Low level of cell-free virus detected at high frequency in saliva from HIV-1-infected individuals. , 1994, AIDS.

[77]  A. Biesbrock,et al.  Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). , 1993, The Journal of biological chemistry.

[78]  C. Haidaris,et al.  Analysis of Candida albicans adhesion to salivary mucin , 1993, Infection and immunity.

[79]  E. Veerman,et al.  Influence of saliva on aggregation and adherence of Streptococcus gordonii HG 222 , 1992, Infection and immunity.

[80]  M. Levine,et al.  Formation of salivary-mucosal pellicle: the role of transglutaminase. , 1992, The Biochemical journal.

[81]  S. Fisher,et al.  Adherence of oral streptococci to salivary glycoproteins , 1992, Infection and immunity.

[82]  G J Strous,et al.  Mucin-type glycoproteins. , 1992, Critical reviews in biochemistry and molecular biology.

[83]  G. Cole,et al.  In vitro inhibition of HIV-1 infectivity by human salivas. , 1990, AIDS research and human retroviruses.

[84]  A. Jamieson,et al.  Viscoelastic properties of solutions of ovine submaxillary mucin , 1990, Biopolymers.

[85]  P. Verdugo.  Goblet cells secretion and mucogenesis. , 1990, Annual review of physiology.

[86]  L. Tabak.  Structure and function of human salivary mucins. , 1990, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[87]  M. Levine,et al.  Characterization of in vivo salivary-derived enamel pellicle. , 1989, Archives of oral biology.

[88]  L. Tabak,et al.  Structural Aspects of Salivary Glycoproteins , 1987, Journal of dental research.

[89]  P. Fultz,et al.  Vaginal transmission of human immunodeficiency virus (HIV) to a chimpanzee. , 1986, The Journal of infectious diseases.

[90]  D. I. Hay,et al.  Strains of Streptococcus mutans and Streptococcus sobrinus attach to different pellicle receptors , 1986, Infection and immunity.

[91]  G. Friedland,et al.  Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. , 1984, The New England journal of medicine.

[92]  L. Tabak,et al.  Adherence of Streptococcus sanguis to salivary mucin bound to glass. , 1982, Journal of dental research.

[93]  L. Tabak,et al.  Specificity of salivary-bacterial interactions: II. Evidence for a lectin on Streptococcussanguis with specificity for a NeuAcα2,3Ga1β1,3Ga1NAc sequence , 1982 .

[94]  L. Tabak,et al.  Role of salivary mucins in the protection of the oral cavity. , 1982, Journal of oral pathology.

[95]  L. Tabak,et al.  Specificity of salivary-bacterial interactions: II. Evidence for a lectin on Streptococcus sanguis with specificity for a NeuAc alpha 2, 3Ga1 beta 1, 3Ga1NAc sequence. , 1982, Biochemical and biophysical research communications.

[96]  R. Gibbons,et al.  Selective Binding of Blood Group-Reactive Salivary Mucins by Streptococcus mutans and Other Oral Organisms , 1978, Infection and immunity.

[97]  M. Levine,et al.  Specificity of salivary-bacterial interactions: role of terminal sialic acid residues in the interaction of salivary glycoproteins with Streptococcus sanguis and Streptococcus mutans , 1978, Infection and immunity.

[98]  S. Dreizen,et al.  Effect of Radiation-Induced Xerostomia on Human Oral Microflora , 1975, Journal of dental research.

[99]  R. Williams,et al.  Inhibition of streptococcal attachment to receptors on human buccal epithelial cells by antigenically similar salivary glycoproteins , 1975, Infection and immunity.